Search clinical trials for: Drug: Carfilzomib + Dexamethasone
Total 254299 results
-
Ajai ChariAmgenCompletedRefractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Universitätsklinikum Hamburg-EppendorfGemeinsamer Bundesausschuss (G-BA); Staburo GmbHRecruiting
-
Henrik GregersenNordic Myeloma Study GroupUnknownMultiple MyelomaFinland, Denmark, Sweden, Norway, Lithuania
-
AmgenActive, not recruitingRelapsed Refractory Multiple MyelomaIndia
-
Janssen Research & Development, LLCTerminatedMultiple MyelomaCanada, United States, Belgium, Poland, Italy, France, Spain, Brazil, Russian Federation, Denmark, Greece, Germany, Netherlands
-
University of ArkansasOnyx Therapeutics, Inc.No longer available
-
M.D. Anderson Cancer CenterOnyx Therapeutics, Inc.TerminatedLymphomaUnited States
-
AmgenCompleted
-
M.D. Anderson Cancer CenterOnyx Therapeutics, Inc.Completed
-
AmgenCompletedHepatic Impairment | Solid Tumors | Hematologic MalignanciesUnited Kingdom, Netherlands, United States, France
-
AmgenCompletedMultiple MyelomaUnited States, Canada
-
European Myeloma NetworkSanofi; Amgen; EMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Germany, Greece, Italy, Netherlands, Norway, Spain
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsRecruiting
-
Washington University School of MedicineCompleted
-
NovartisAmgenTerminated
-
Thomas LundRecruiting
-
Central Hospital, Nancy, FranceNot yet recruiting
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania
-
Christian BuskeAmgen; Janssen, LPRecruitingWaldenstrom MacroglobulinemiaAustria, Germany, Greece
-
AmgenMultiple Myeloma Research FoundationApproved for marketing
-
AmgenCompletedEnd-stage Renal Disease | Relapsed Multiple MyelomaUnited States, Australia, Canada
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
University of NebraskaM.D. Anderson Cancer CenterTerminatedCabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple MyelomaMultiple Myeloma | Refractory Multiple Myeloma | Relapsed/Refractory Multiple MyelomaUnited States
-
Hackensack Meridian HealthSuspendedMultiple MyelomaUnited States
-
Children's Hospital Medical Center, CincinnatiBill and Melinda Gates Foundation; Syngene InternationalCompleted
-
University of NebraskaNational Cancer Institute (NCI); AmgenCompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Recurrent Adult T-cell Leukemia/LymphomaUnited States
-
SCRI Development Innovations, LLCAmgenCompletedNeuroendocrine CancerUnited States
-
John F. McDyer, MDCompletedLung Transplant RejectionUnited States
-
OncotherapeuticsAmgenUnknownMultiple MyelomaUnited States
-
Seoul National University Bundang HospitalCompletedEvaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or BetamethasoneBack Pain | Neck PainKorea, Republic of
-
Ahmadu Bello University Teaching HospitalCompletedNeonatal Respiratory Distress SyndromeNigeria
-
AmgenCompletedRenal Insufficiency | Multiple MyelomaUnited States
-
University of OklahomaStony Brook UniversityCompletedIntraventricular Hemorrhage | Respiratory Distress Syndrome | Neonatal MortalityUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
Spectrum Health HospitalsCompletedMultiple MyelomaUnited States
-
OncotherapeuticsAmgenCompletedMultiple MyelomaUnited States
-
AmgenCompletedMultiple Myeloma | Solid TumorsUnited States, Canada
-
Sheba Medical CenterUnknown
-
SanofiRecruitingRelapsed/Refractory Multiple MyelomaCzechia, Japan, Australia, Brazil, Greece, Portugal
-
Columbia UniversityTerminatedHodgkin Disease | Lymphoma, Non-hodgkinUnited States
-
M.D. Anderson Cancer CenterAmgen; Pharmacyclics LLC.Terminated
-
Peking University First HospitalRecruitingMultiple Myeloma | Renal InjuryChina
-
AmgenCompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Attaya SuvannasankhaNational Cancer Institute (NCI)TerminatedRefractory Multiple MyelomaUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownScars | Keloid | Hypertrophic Scar | Scarring
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada
-
AmgenOnyx Therapeutics, Inc.CompletedRelapsed and Refractory Multiple MyelomaChina
-
AmgenCompletedLymphoma | Small Cell Lung Cancer | Multiple Myeloma | Ovarian Cancer | Non-small Cell Lung Cancer | Solid Tumors | Renal CancerUnited States
-
AmgenCompletedMultiple MyelomaUnited States